BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11274596)

  • 41. 'In vivo' time course of plasma myeloperoxidase levels after granulocyte colony-stimulating factor-induced stem cell mobilization.
    Morabito F; Tomaino A; Cristani M; Martino M; Minciullo PL; Saija A; Gangemi S
    Transfus Med; 2005 Oct; 15(5):425-8. PubMed ID: 16202058
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Granulocyte transfusion in the G-CSF era.
    Price TH
    Int J Hematol; 2002 Aug; 76 Suppl 2():77-80. PubMed ID: 12430904
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Safety of growth factor administration for leukapheresis in those with WBC counts greater than 60,000/µl.
    Chen W; Rizzieri D; Drago S
    J Clin Apher; 2015 Feb; 30(1):28-31. PubMed ID: 24975628
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Randomised vehicle-controlled dose-finding study of glycosylated recombinant human granulocyte colony-stimulating factor after bone marrow transplantation.
    Linch DC; Scarffe H; Proctor S; Chopra R; Taylor PR; Morgenstern G; Cunningham D; Burnett AK; Cawley JC; Franklin IM
    Bone Marrow Transplant; 1993 Apr; 11(4):307-11. PubMed ID: 7683552
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor.
    Cavallaro AM; Lilleby K; Majolino I; Storb R; Appelbaum FR; Rowley SD; Bensinger WI
    Bone Marrow Transplant; 2000 Jan; 25(1):85-9. PubMed ID: 10654020
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The increase of the rate of hemopoietic recovery and clinical benefit of the erythropoietin (EPO) and granulocyte colony-stimulating factor (G-CSF) with peripheral blood progenitor cells (PBPC) after intensive cyclic chemotherapy in high-risk breast cancer patients.
    Filip S; Vanásek J; Bláha M; Mericka P; Vávrová J; Podzimek K
    Neoplasma; 1999; 46(3):166-72. PubMed ID: 10613592
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tolerance of sequential or simultaneous administration of IL-3 and G-CSF in improving peripheral blood stem cells harvesting following multi-agent chemotherapy: a pilot study.
    D'Hondt V; Guillaume T; Humblet Y; Doyen C; Chatelain B; Feyens AM; Staquet P; Osselaer JC; Müll B; Symann M
    Bone Marrow Transplant; 1994 Mar; 13(3):261-4. PubMed ID: 7515299
    [TBL] [Abstract][Full Text] [Related]  

  • 48. rhG-CSF in healthy donors: mobilization of peripheral hemopoietic progenitors and effect on peripheral blood leukocytes.
    Sica S; Rutella S; Di Mario A; Salutari P; Rumi C; Ortu la Barbera E; Etuk B; Menichella G; D'Onofrio G; Leone G
    J Hematother; 1996 Aug; 5(4):391-7. PubMed ID: 8877714
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transient respiratory disturbance by granulocyte-colony-stimulating factor administration in healthy donors of allogeneic peripheral blood progenitor cell transplantation.
    Yoshida I; Matsuo K; Teshima T; Hashimoto D; Tanimoto Y; Harada M; Tanimoto M
    Transfusion; 2006 Feb; 46(2):186-92. PubMed ID: 16441593
    [TBL] [Abstract][Full Text] [Related]  

  • 50. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft.
    Dreger P; Haferlach T; Eckstein V; Jacobs S; Suttorp M; Löffler H; Müller-Ruchholtz W; Schmitz N
    Br J Haematol; 1994 Jul; 87(3):609-13. PubMed ID: 7527648
    [TBL] [Abstract][Full Text] [Related]  

  • 51. How do I provide leukapheresis products? Blood center experience and evidence for process improvement.
    Ginzburg Y; Kessler D; Narici M; Caltabiano M; Rebosa M; Strauss D; Shaz B
    Transfusion; 2013 Oct; 53(10):2123-9. PubMed ID: 23113726
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison between once a day vs twice a day G-CSF for mobilization of peripheral blood progenitor cells (PBPC) in normal donors for allogeneic PBPC transplantation.
    Arbona C; Prosper F; Benet I; Mena F; Solano C; Garcia-Conde J
    Bone Marrow Transplant; 1998 Jul; 22(1):39-45. PubMed ID: 9678794
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Donor tolerance and results of stimulation with G-CSF alone or in combination with dexamethasone for the collection of granulocytes.
    Moog R
    J Clin Apher; 2004; 19(3):115-8. PubMed ID: 15493056
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Autologous peripheral blood stem cell transplantation using simplified procedures for collection and freezing.
    Hwang WL; Tsai CS; Jour JH; Kuo LH; Chang YM
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Aug; 62(8):529-35. PubMed ID: 10462830
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Granulocyte colony-stimulating factor-mobilized granulocyte concentrate transfusions.
    Price TH
    Curr Opin Hematol; 1998 Nov; 5(6):391-5. PubMed ID: 9814645
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Kinetics of peripheral blood mononuclear cell mobilization with chemotherapy and/or granulocyte-colony-stimulating factor: implications for yield of hematopoietic progenitor cell collections.
    Webb IJ; Eickhoff CE; Elias AD; Ayash LJ; Wheeler CA; Schwartz GN; Demetri GD; Anderson KC
    Transfusion; 1996 Feb; 36(2):160-7. PubMed ID: 8614968
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased serum flt3-ligand in healthy donors undergoing granulocyte colony-stimulating factor-induced peripheral stem cell mobilization.
    Dettke M; Jurko S; Rüger BM; Leitner G; Greinix HT; Kalhs P; Fischer MB; Höcker P
    J Hematother Stem Cell Res; 2001 Apr; 10(2):317-20. PubMed ID: 11359680
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Peripheral blood progenitor cell collection without close monitoring of peripheral blood CD34+ cells: A feasible strategy for multiple myeloma or pre-treated Non-Hodgkin's Lymphoma patients mobilized with low-dose cyclophosphamide plus G-CSF.
    Callera F; Cavenaghi L; de Melo CM
    Transfus Apher Sci; 2009 Apr; 40(2):91-5. PubMed ID: 19233728
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effective stimulation of donors for granulocyte transfusions with recombinant methionyl granulocyte colony-stimulating factor.
    Caspar CB; Seger RA; Burger J; Gmür J
    Blood; 1993 Jun; 81(11):2866-71. PubMed ID: 7684619
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Granulocyte collection efficiency and yield are enhanced by the use of a higher interface offset during apheresis of donors given granulocyte-colony-stimulating factor.
    Adkins D; Ali S; Despotis G; Dynis M; Goodnough LT
    Transfusion; 1998 Jun; 38(6):557-64. PubMed ID: 9661689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.